Good moveThe dilution with 6.3 millions shares at 1$/share is indeed in the actual circumstance a great move. Although it didn't add cash to the company it gives in the long run 50% more revenue with only 17% dilution. Time will tell if RBP can deliver more and more revenue. My guess is yes with LND cross sell expertise especially in the healthcare businesses.